A randomized phase II trial of continuous infusion interleukin-2 or bolus injection interleukin-2 plus lymphokine-activated killer cells for advanced renal cell carcinoma

Geoffrey R. Weiss, Kim A. Mongolin, Frederick R. Aronson, Mario Sznol, Michael B. Atkins, Janice P. Dutcher, Ellen R. Gaynor, David H. Boldt, James H. Doroshow, Michael H. Bar, Michael J. Hawkins, Paul A. Demchak, Rasim Gucalp, Richard I. Fisher

Research output: Contribution to journal › Article › peer-review

142 Scopus citations

Fingerprint

Dive into the research topics of 'A randomized phase II trial of continuous infusion interleukin-2 or bolus injection interleukin-2 plus lymphokine-activated killer cells for advanced renal cell carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences